AWED试验:利用沃尔巴克氏体感染蚊虫降低印尼日惹登革热发病率——整群随机对照试验研究方案
该研究方案旨在评估在印尼日惹大规模释放感染沃尔巴克氏体的埃及伊蚊能否降低登革热发病率。研究采用平行双组非盲整群随机对照试验设计,将26平方公里区域分为24个连续整群,按1:1随机分配接受沃尔巴克氏体释放或不干预。主要终点为有症状且病毒学确诊的登革热感染,采用整群随机测试阴性设计,通过比较病例与测试阴性对照的沃尔巴克氏体暴露比值比来估计效果。
要点
- 首个在现场评估沃尔巴克氏体降低登革热传播效果的整群随机对照试验。
- 在印尼日惹26平方公里区域开展,24个整群按1:1随机分配干预。
- 主要终点为有症状且病毒学确诊的登革热感染。
核心结论
- 该研究方案将提供沃尔巴克氏体降低登革热发病率的首个实验证据。
- 结合其他现场积累的观察性证据,可估算该新方法的有效性并指导大规模部署。
研究设计与样本
- 平行、两组、非盲、单中心整群随机对照试验,在印度尼西亚日惹开展。
- 研究区域26平方公里,分为24个连续整群,按1:1随机分配接受沃尔巴克氏体释放或不干预。
- 主要终点为任何严重程度的有症状且病毒学确诊的登革热病毒感染。
- 采用整群随机测试阴性设计,从初级保健诊所网络就诊的发热患者中同时采样登革热病例和虫媒病毒阴性对照。
- 通过比较病毒学确诊登革热病例与测试阴性对照的沃尔巴克氏体暴露分布(居住在释放区的概率)的比值比来估计效果。
关键数值与推荐
- 主要分析通过比值比估计效果,比较病例与对照的沃尔巴克氏体暴露分布。
- 次要符合方案分析允许评估个体沃尔巴克氏体暴露水平,以考虑集群外活动及释放整群内当地沃尔巴克氏体流行率的异质性。
临床怎么用
- 若证实有效,可为登革热及其他虫媒病毒控制提供新型生物干预策略。
- 研究结果可指导未来成本效果评估及在其他流行区的大规模部署计划。
局限性
- 研究设计为非盲,可能存在偏倚。
- 仅在单一地点开展,外推性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dengue and other arboviruses transmitted by Aedes aegypti mosquitoes, including Zika and chikungunya, present an increasing public health challenge in tropical regions. Current vector control strategies have failed to curb disease transmission, but continue to be employed despite the absence of robust evidence for their effectiveness or optimal implementation. The World Mosquito Program has developed a novel approach to arbovirus control using Ae. aegypti stably transfected with Wolbachia bacterium, with a significantly reduced ability to transmit dengue, Zika and chikungunya in laboratory experiments. Modelling predicts this will translate to local elimination of dengue in most epidemiological settings. This study protocol describes the first trial to measure the efficacy of Wolbachia in reducing dengue virus transmission in the field. METHODS/DESIGN: The study is a parallel, two-arm, non-blinded cluster randomised controlled trial conducted in a single site in Yogyakarta, Indonesia. The aim is to determine whether large-scale deployment of Wolbachia-infected Ae. aegypti mosquitoes leads to a measurable reduction in dengue incidence in treated versus untreated areas. The primary endpoint is symptomatic, virologically confirmed dengue virus infection of any severity. The 26 km2 study area was subdivided into 24 contiguous clusters, allocated randomly 1:1 to receive Wolbachia deployments or no intervention. We use a novel epidemiological study design, the cluster-randomised test-negative design trial, in which dengue cases and arbovirus-negative controls are sampled concurrently from among febrile patients presenting to a network of primary care clinics, with case or control status classified retrospectively based on the results of laboratory diagnostic testing. Efficacy is estimated from the odds ratio of Wolbachia exposure distribution (probability of living in a Wolbachia-treated area) among virologically confirmed dengue cases compared to test-negative controls. A secondary per-protocol analysis allows for individual Wolbachia exposure levels to be assessed to account for movements outside the cluster and the heterogeneity in local Wolbachia prevalence among treated clusters. DISCUSSION: The findings from this study will provide the first experimental evidence for the efficacy of Wolbachia in reducing dengue incidence. Together with observational evidence that is accumulating from pragmatic deployments of Wolbachia in other field sites, this will provide valuable data to estimate the effectiveness of this novel approach to arbovirus control, inform future cost-effectiveness estimates, and guide plans for large-scale deployments in other endemic settings. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT03055585 . Registered on 14 February 2017.
引用
- Anders KL, Indriani C, Ahmad RA, et al. The AWED trial (Applying Wolbachia to Eliminate Dengue) to assess the efficacy of Wolbachia-infected mosquito deployments to reduce dengue incidence in Yogyakarta, Indonesia: study protocol for a cluster randomised controlled trial. Trials. 2018. PMID: 29855331. doi:10.1186/s13063-018-2670-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。